Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma. | Front Immunol | 2022 | 36457998 | PubTator, text mining | PubMed |
| The role of Staphylococcus aureus small colony variants in intraosseous invasion and colonization in periprosthetic joint infection. | Bone Joint Res | 2022 | 36453022 | PubTator, text mining | PubMed |
| Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study. | Cancer Cell Int | 2022 | 36451206 | PubTator, text mining | PubMed |
| The modulation of macrophage subsets in celiac disease pathogenesis. | Immun Inflamm Dis | 2022 | 36444633 | PubTator, text mining | PubMed |
| The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors. | Front Oncol | 2022 | 36439457 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer. | Front Immunol | 2022 | 36439090 | PubTator, text mining | PubMed |
| Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. | Theranostics | 2022 | 36438481 | PubTator, text mining | PubMed |
| The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. | Cell Oncol (Dordr) | 2022 | 36435866 | PubTator, text mining | PubMed |
| CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease. | Nat Commun | 2022 | 36433996 | PubTator, text mining | PubMed |
| Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC. | Pharmaceutics | 2022 | 36432658 | PubTator, text mining | PubMed |
| Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. | Pharmaceutics | 2022 | 36432643 | PubTator, text mining | PubMed |
| Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy. | Int J Mol Sci | 2022 | 36430817 | PubTator, text mining | PubMed |
| Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention. | Int J Mol Sci | 2022 | 36430404 | PubTator, text mining | PubMed |
| Small Tweaks, Major Changes: Post-Translational Modifications That Occur within M2 Macrophages in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36428622 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes. | Biomedicines | 2022 | 36428508 | PubTator, text mining | PubMed |
| Atopic Dermatitis: Clinical Aspects and Unmet Needs. | Biomedicines | 2022 | 36428493 | PubTator, text mining | PubMed |
| Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis. | Front Med (Lausanne) | 2022 | 36425108 | PubTator, text mining | PubMed |
| Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma. | BMC Cancer | 2022 | 36424539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=52